Improving Medication Safety and CVD Risk Factor Control in Kidney Transplant Recipients

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

January 22, 2018

Study Completion Date

January 22, 2018

Conditions
Cardiovascular DiseasesDiabetes MellitusMedication Adherence
Interventions
BEHAVIORAL

Pharmacist-led, technology enabled education intervention

Prospective, non-randomized, pilot study assessing the feasibility and potential efficacy of a 6-month, pharmacist-led, technology enabled education intervention on improving medication safety and cardiovascular risk factor control in adult solitary kidney transplant recipients with a secondary aim of assessing if the impact of the intervention varies by race.

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Medical University of South Carolina

OTHER

NCT02763943 - Improving Medication Safety and CVD Risk Factor Control in Kidney Transplant Recipients | Biotech Hunter | Biotech Hunter